Skip to main content
. 2013 Dec 13;14:350. doi: 10.1186/1471-2474-14-350

Figure 1.

Figure 1

Cost-effectiveness planes of 1000 bootstrap replicates of the incremental cost and effectiveness (based on the number of patients in remission, defined as a Disease Activity Score in 28 joints < 2.6) of the treat-to-target strategy versus usual care in early rheumatoid arthritis after A) two years and B) three years of follow-up.